ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,282 | -11.7% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $39,962 | -14.7% | 1,300 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $46,839 | -12.9% | 1,300 | -4.4% | 0.01% | -11.1% |
| Q4 2022 | $53,747 | -0.5% | 1,360 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $54,000 | -6.9% | 1,360 | -0.3% | 0.01% | -9.1% |
| Q2 2022 | $58,000 | +13.7% | 1,364 | +4.9% | 0.01% | +22.2% |
| Q1 2022 | $51,000 | -1.9% | 1,300 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $52,000 | +10.6% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $47,000 | -11.3% | 1,300 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $53,000 | -7.0% | 1,300 | 0.0% | 0.01% | -21.4% |
| Q1 2021 | $57,000 | -12.3% | 1,300 | 0.0% | 0.01% | -17.6% |
| Q4 2020 | $65,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |